RODNEY B. NELSON III, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: The paper by DeVita and colleagues (1) on curability of Hodgkin's disease with combination chemotherapy seems misleadingly optimistic. In the abstract appears the statement ". . . 68% of patients achieving a complete remission have remained disease free beyond 10 years from the end of treatment," which is misleading for three reasons.
First, the 68% figure is an error; at least it is inconsistent with the data presented in the text and figures. The true figure should have been 63.5%. This is a minor, if somewhat careless, mistake and is not the only numerical inconsistency in the
NELSON RB. Combination Chemotherapy for Hodgkin's Disease. Ann Intern Med. ;94:713–714. doi: 10.7326/0003-4819-94-5-713_2
Download citation file:
Published: Ann Intern Med. 1981;94(5):713-714.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use